​

Eli Lilly (LLY) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

LLY Stock Forecast

Eli Lilly (LLY) stock forecast, based on 45 Wall Street analysts, predicts a 12-month average price target of $1,315.42, with a high of $1,500.00 and a low of $1,135.00. This represents a 9.80% increase from the last price of $1,197.99.

$550 $740 $930 $1 $1 $1 High: $1500 Avg: $1315.42 Low: $1135 Last Closed Price: $1197.99

LLY Stock Rating

Eli Lilly stock's rating consensus is Buy, based on 45 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 33 Buy (73.33%), 9 Hold (20.00%), 3 Sell (6.67%), and 0 Strong Sell (0.00%).

Buy
Total 45 0 3 9 33 Strong Sell Sell Hold Buy Strong Buy

LLY Price Target Upside V Benchmarks

TypeNameUpside
StockEli Lilly9.80%
SectorHealthcare Stocks 15.45%
IndustryDrug Manufacturers - General Stocks6.23%

Price Target Trends

1M3M12M
# Anlaysts81750
Avg Price Target$1.38K$1.32K$1.21K
Last Closing Price$1.20K$1.20K$1.20K
Upside/Downside14.98%10.14%0.78%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jul, 2661751130
Jun, 2661851131
May, 2661861-31
Apr, 2661861-31
Mar, 266186-131
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jul 14, 2026Bernstein$1.39K$1.19K16.87%15.61%
Jul 13, 2026UBS$1.43K$1.19K19.76%18.95%
Jul 13, 2026Guggenheim$1.27K$1.19K7.10%6.26%
Jul 09, 2026UBS$1.37K$1.22K12.10%14.36%
Jul 08, 2026Truist Financial$1.37K$1.23K11.65%14.36%
Jul 08, 2026RBC Capital$1.50K$1.23K22.03%25.21%
Jul 08, 2026Terence FlynnMorgan Stanley$1.35K$1.24K9.02%12.44%
Jul 06, 2026Cantor Fitzgerald$1.35K$1.21K11.52%12.69%
Jun 25, 2026David RisingerLeerink Partners$1.23K$1.12K10.27%2.84%
Jun 22, 2026Kerry HolfordBerenberg Bank$1.14K$1.11K2.10%-5.26%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jul 15, 2026CitigroupBuyBuyhold
Jul 14, 2026BernsteinOutperformOutperformhold
Jul 13, 2026UBSBuyBuyhold
Jul 13, 2026GuggenheimBuyBuyhold
Jul 08, 2026RBC CapitalOutperformOutperformhold
Jul 08, 2026Morgan StanleyOverweightOverweighthold
Jun 22, 2026Cantor FitzgeraldOverweightOverweighthold
Jun 15, 2026BMO CapitalOutperformOutperformhold
Jun 09, 2026JefferiesBuyBuyhold
Jun 08, 2026BernsteinOutperformOutperformhold

Financial Forecast

EPS Forecast

$5 $13 $21 $29 $37 $45 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$5.85$6.57$5.83$11.76$23.00---
Avg Forecast$8.13$7.64$6.23$12.95$22.49$29.14$34.70$41.01
High Forecast$9.04$8.56$6.58$13.35$27.77$33.34$41.05$43.17
Low Forecast$7.42$6.99$5.86$12.41$21.13$23.61$25.96$39.12
Surprise %-28.04%-14.01%-6.42%-9.19%2.27%---

Revenue Forecast

$25B $39B $53B $67B $81B $95B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$28.32B$28.54B$34.12B$45.04B$65.18B---
Avg Forecast$28.04B$28.59B$33.65B$45.31B$58.51B$70.05B$79.12B$89.33B
High Forecast$30.46B$31.25B$33.90B$45.68B$59.01B$70.10B$79.63B$92.95B
Low Forecast$26.15B$26.74B$33.44B$45.00B$58.02B$70.00B$78.61B$86.17B
Surprise %0.99%-0.17%1.40%-0.58%11.41%---

Net Income Forecast

$0 $8B $16B $24B $32B $40B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$5.58B$6.24B$5.24B$10.59B$20.64B---
Avg Forecast$5.76B$5.98B$5.24B$11.63B$19.44B$24.80B$30.38B$37.04B
High Forecast$6.92B$7.17B$6.29B$12.06B$25.08B$30.11B$37.08B$39.00B
Low Forecast$4.61B$4.78B$4.19B$11.21B$19.09B$21.33B$23.45B$35.34B
Surprise %-3.15%4.45%--8.95%6.14%---

LLY Forecast FAQ

Is Eli Lilly stock a buy?

Eli Lilly stock has a consensus rating of Buy, based on 45 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 33 Buy, 9 Hold, 3 Sell, and 0 Strong Sell, reflecting a consensus that Eli Lilly is a favorable investment for most analysts.

What is Eli Lilly's price target?

Eli Lilly's price target, set by 45 Wall Street analysts, averages $1.32K over the next 12 months. The price target range spans from $1.14K at the low end to $1.5K at the high end, suggesting a potential 9.80% change from the previous closing price of $1.2K.

How does Eli Lilly stock forecast compare to its benchmarks?

Eli Lilly's stock forecast shows a 9.80% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the drug manufacturers - general stocks industry (6.23%).

What is the breakdown of analyst ratings for Eli Lilly over the past three months?

  • July 2026: 20.00% Strong Buy, 56.67% Buy, 16.67% Hold, 3.33% Sell, 3.33% Strong Sell.
  • June 2026: 19.35% Strong Buy, 58.06% Buy, 16.13% Hold, 3.23% Sell, 3.23% Strong Sell.
  • May 2026: 19.35% Strong Buy, 58.06% Buy, 19.35% Hold, 3.23% Sell, 0% Strong Sell.

What is Eli Lilly’s EPS forecast?

Eli Lilly's average annual EPS forecast for its fiscal year ending in December 2026 is $29.14, marking a 26.70% increase from the reported $23 in 2025. Estimates for the following years are $34.7 in 2027, and $41.01 in 2028.

What is Eli Lilly’s revenue forecast?

Eli Lilly's average annual revenue forecast for its fiscal year ending in December 2026 is $70.05B, reflecting a 7.48% increase from the reported $65.18B in 2025. The forecast for 2027 is $79.12B, and $89.33B for 2028.

What is Eli Lilly’s net income forecast?

Eli Lilly's net income forecast for the fiscal year ending in December 2026 stands at $24.8B, representing an 20.17% increase from the reported $20.64B in 2025. Projections indicate $30.38B in 2027, and $37.04B in 2028.